Diagnostics & Research Stocks in India
Finoron tracks 13 listed companies in the Diagnostics & Research industry, with a combined market capitalisation of ₹1.25 L Cr. The median price-to-earnings ratio across its profitable companies is 59.9. The largest by market capitalisation are Sai Life Sciences, Dr. Lal PathLabs and Vijaya Diagnostic Centre.
All 13 companies by market capitalisation
| Company | Price | Change | Market Cap | P/E |
|---|---|---|---|---|
| Sai Life SciencesSAILIFE | ₹1,590.00 | -0.31% | ₹33,821 Cr | 93.4 |
| Dr. Lal PathLabsLALPATHLAB | ₹1,980.00 | +0.95% | ₹32,599 Cr | 60.2 |
| Vijaya Diagnostic CentreVIJAYA | ₹1,528.00 | +0.10% | ₹15,590 Cr | 83.3 |
| Syngene InternationalSYNGENE | ₹380.35 | +0.00% | ₹15,243 Cr | 69.0 |
| Metropolis HealthcareMETROPOLIS | ₹584.95 | +0.34% | ₹12,086 Cr | 59.9 |
| Thyrocare TechnologiesTHYROCARE | ₹566.20 | -0.10% | ₹9,022 Cr | 51.4 |
| Vimta LabsVIMTALABS | ₹602.35 | +0.81% | ₹2,679 Cr | 33.6 |
| Suraksha DiagnosticSURAKSHA | ₹354.30 | -0.48% | ₹1,788 Cr | 50.0 |
| Krsnaa DiagnosticsKRSNAA | ₹552.00 | +0.14% | ₹1,779 Cr | 18.5 |
| Aspira Pathlab & DiagnosticsASPIRA | ₹130.02 | +0.02% | ₹134 Cr | — |
| Choksi LaboratoriesCHOKSILA | ₹190.05 | -4.52% | ₹132 Cr | 60.9 |
| Samsrita LabsSAMSRITA | ₹12.41 | +0.32% | ₹28 Cr | — |
| Dolphin Medical ServicesDOLPHMED | ₹6.30 | +0.00% | ₹10 Cr | 57.3 |